Biomodex Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 34
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $3.9M
Latest Deal Amount
  • Investors
  • 9

Biomodex General Information

Description

Developer of a 3D-printed technology designed for patient-specific rehearsal and physicians' advanced training. The company's technology combines biomechanical and imaging properties (4D) fluid dynamics (5D) and is fully integrated into both the imaging and procedural workflow, enabling treating physicians to increase their preparedness and confidence and ultimately reducing surgical medical errors and medical costs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 2 rue de la Roquette
  • 75011 Paris
  • France

Biomodex Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biomodex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 29-May-2020 $3.9M 000.00 000.00 Completed Generating Revenue
5. Early Stage VC 04-Oct-2019 00.000 000.00 000.00 Completed Generating Revenue
4. Early Stage VC (Series A) 30-May-2018 000.00 000.00 000.00 Completed Generating Revenue
3. Accelerator/Incubator 14-Nov-2017 00.000 Completed Generating Revenue
2. Early Stage VC (Series A) 11-Apr-2016 $4.06M $4.06M 00.000 Completed Generating Revenue
1. Accelerator/Incubator 05-May-2015 Completed Generating Revenue
To view Biomodex’s complete valuation and funding history, request access »

Biomodex Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
OCABSA 00,000 00.000000 000.00 000.00 00 000.00 0.000
B Shares 000,000 00.000000 000.00 000.00 00 000.00 00.000
ABSA-B2018 33,105 $0.109088 $60.41 $60.41 1x $60.41 7.68%
A Shares 133,200 $0.109088 $22.11 $22.11 1x $22.11 30.92%
To view Biomodex’s complete cap table history, request access »

Biomodex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a 3D-printed technology designed for patient-specific rehearsal and physicians' advanced training. The comp
Surgical Devices
Paris, France
34 As of 2021
000.00
00.00 0000-00-00
0000000000 0 000.00

00000 &

olor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
00000 0000000000 00000000
Bristol, United Kingdom
0 As of 0000

0000000

iam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute ir
00000 0000000 000 00000000
Seattle, WA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biomodex Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Limbs & Things Corporation Bristol, United Kingdom 0
0000000 0000000000 Corporation Seattle, WA
0000000 0000000 Corporation Stavanger, Norway
0000000 Formerly VC-backed Gothenburg, Sweden 000 000.00 00000000000 000.00
00 0000000 Formerly VC-backed Rock Hill, SC 0000 000000 - 000
You’re viewing 5 of 8 competitors. Get the full list »

Biomodex Executive Team (8)

Name Title Board Seat Contact Info
Ziad Rouag JD Chief Executive Officer & President
Anne-Charlotte Millard Group Finance Director
Karl Schweitzer JD Chairman
You’re viewing 3 of 8 executive team members. Get the full list »

Biomodex Board Members (7)

Name Representing Role Since
François Thomas MD Inserm Transfert Board Member 000 0000
Jean-Luc Boulnois Ph.D Self Board Member 000 0000
Karl Schweitzer JD Biomodex Chairman 000 0000
Luc Maruenda Idinvest Partners Board Member 000 0000
Richard Ferrari Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Biomodex Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biomodex Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Idinvest Partners PE/Buyout Minority 000 0000 000000 0
InnovAllianz Corporate Venture Capital Minority 000 0000 000000 0
Sofimac Innovation Venture Capital Minority 000 0000 000000 0
3DEXPERIENCE Lab Accelerator/Incubator Minority 000 0000 000000 0
Innovation Capital (Paris) Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »